NEWS

January 30, 2024
DIAGNODE 3 STUDY: DIABETES VACCINE DIAMYD® (GAD65-ALUM) IN PEOPLE WITH HLA DR3-DQ2 HAPLOTYPE
Earlier we reported publication of the first results of the Diagnode-1 and Diagnode-2 studies, testing Diamyd Medical's diabetes vaccine GAD-alum (Diamyd®) in people with recently diagnosed type 1 diabetes. Diamyd Medical is now recruiting people for the Diagnode 3 study.
June 20, 2023
UPDATE PUBLICATIONS
We have updated the Diabeter Research website with a number of publications of studies in which Diabeter authors were involved:

Home

Welcome to the research website of Diabeter. Here you will find details and explanations of why we do research, how we do research, and how the results are translated into improved care for children, adolescents and adults with type 1 diabetes. Additionally we will keep you up-to-date on the availability for inclusion in studies we are running or are participating in.

 

There are sections covering our different lines of research, publications and collaborations, plus a news section highlighting our activities and the most important developments in the field.

 

Often we will collaborate on research with other partners. We have much to offer, including a large biobank and database that enable us to conduct truly meaningful and clinically relevant studies. Please get in touch if you want to learn more.

© 2024 Diabeter | Terms of Use | Privacy Statement